New Book Reveals the Story Behind Regenokine, the Breakthrough Osteoarthritis Treatment Successfully Used in Europe for the Last Decade

LOS ANGELES, Jan. 5, 2012 /PRNewswire/ -- A new book detailing the story behind the development of the Regenokine Treatment Program, a breakthrough treatment for osteoarthritis, chronic back and joint pain, has just been published and is available now for download on Amazon.com and iTunes.com.

"The End of Pain: The Game Changing New Treatment Against Osteoarthritis and Low Back Pain" tells how German orthopedic surgeon Dr. Peter Wehling first discovered the formula for the Regenokine treatment and then teamed up with renowned preventive medicine expert in the U.S., Dr. Chris Renna, to create the Regenokine Treatment Program. The two doctors co-authored the book.

Regenokine recently came to the attention of the American public when legendary golfer Fred Couples, who for years was incapacitated by debilitating arthritic back pain, won the PGA Senior Players Championship on August 28th, 2011 and attributed his victory to the treatment he received in Germany.

"I had the Regenokine treatment, and after just a few weeks I was able to resume my regular playing schedule and I feel fantastic. I have been suffering with back problems for many years, and this treatment has really decreased my pain and allowed me to forget about my back and focus on playing my best. I am feeling better than I have in 10 years," said Couples.

Dr. Renna, who heads the LifeSpan Medicine clinics in Los Angeles and Dallas, has begun offering the Regenokine Treatment for the first time in the Unites States. Prior to its introduction here, Regenokine was used by thousands of individuals in Europe including Pope John Paul II, pro athletes, celebrities, politicians and business magnates.

The book reveals how Regenokine, which uses a small volume of the patient's own blood to create a serum that reduces inflammation, was met initially with fierce resistance by the medical establishment. Ultimately, the remarkable results achieved for patients, some of whom had given up all hope of treatment for their chronic back and joint pain, turned the tide of opinion. In his introduction to the book, Christopher Evans, Ph.D., D.Sc, Professor of Orthopedic Surgery at Harvard Medical School, says, "The success of the Regenokine Program speaks for itself and it will continue to thrive."

For the complete story of the Regenokine Treatment Program please go to Amazon.com or iTunes.com to view the book.

More information about the Regenokine Treatment Program is available online: LifeSpanmedicine.com.

Media Contact:
Gina Renna
310-453-2335 (office)
[email protected] 

SOURCE Regenokine Treatment Program